These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24884998)

  • 41. Neuroprotector effect of stem cells from human exfoliated deciduous teeth transplanted after traumatic spinal cord injury involves inhibition of early neuronal apoptosis.
    Nicola FDC; Marques MR; Odorcyk F; Arcego DM; Petenuzzo L; Aristimunha D; Vizuete A; Sanches EF; Pereira DP; Maurmann N; Dalmaz C; Pranke P; Netto CA
    Brain Res; 2017 May; 1663():95-105. PubMed ID: 28322752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury.
    Zhou Y; Wang Y; Abdelhady M; Mourad MS; Hassouna MM
    J Surg Res; 2002 Sep; 107(1):140-4. PubMed ID: 12384077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of rat urinary bladder during acute phase of spinal cord injury.
    Mimata H; Satoh F; Tanigawa T; Nomura Y; Ogata J
    Urol Int; 1993; 51(2):89-93. PubMed ID: 8351761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
    Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
    Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
    Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder.
    Balsara ZR; Ross SS; Dolber PC; Wiener JS; Tang Y; Seed PC
    Infect Immun; 2013 Aug; 81(8):3018-26. PubMed ID: 23753628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI.
    Johnson PJ; Tatara A; Shiu A; Sakiyama-Elbert SE
    Cell Transplant; 2010; 19(1):89-101. PubMed ID: 19818206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoring both continence and micturition after chronic spinal cord injury by pudendal neuromodulation.
    Guo W; Shapiro K; Wang Z; Armann K; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
    Exp Neurol; 2021 Jun; 340():113658. PubMed ID: 33639209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulatory effects of intravesical P2X2/3 purinergic receptor inhibition on lower urinary tract electromyographic properties and voiding function of female rats with moderate or severe spinal cord injury.
    Salazar BH; Hoffman KA; Zhang C; Zhang Y; Cruz Y; Boone TB; Munoz A
    BJU Int; 2019 Mar; 123(3):538-547. PubMed ID: 30255543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-Nitrosoglutathione protects the spinal bladder: novel therapeutic approach to post-spinal cord injury bladder remodeling.
    Shunmugavel A; Khan M; Hughes FM; Purves JT; Singh A; Singh I
    Neurourol Urodyn; 2015 Aug; 34(6):519-26. PubMed ID: 24853799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary study of a genetically engineered spinal cord implant on urinary bladder after experimental spinal cord injury in rats.
    Sakamoto K; Uvelius B; Khan T; Damaser MS
    J Rehabil Res Dev; 2002; 39(3):347-57. PubMed ID: 12173755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-surgical urologic management of neurogenic bladder after spinal cord injury.
    Romo PGB; Smith CP; Cox A; Averbeck MA; Dowling C; Beckford C; Manohar P; Duran S; Cameron AP
    World J Urol; 2018 Oct; 36(10):1555-1568. PubMed ID: 30051263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serial changes in bladder, locomotion, and levels of neurotrophic factors in rats with spinal cord contusion.
    Hyun JK; Lee YI; Son YJ; Park JS
    J Neurotrauma; 2009 Oct; 26(10):1773-82. PubMed ID: 19203225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-Nogo-A Antibodies As a Potential Causal Therapy for Lower Urinary Tract Dysfunction after Spinal Cord Injury.
    Schneider MP; Sartori AM; Ineichen BV; Moors S; Engmann AK; Hofer AS; Weinmann O; Kessler TM; Schwab ME
    J Neurosci; 2019 May; 39(21):4066-4076. PubMed ID: 30902870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury.
    Gómez-Villafuertes R; Rodríguez-Jiménez FJ; Alastrue-Agudo A; Stojkovic M; Miras-Portugal MT; Moreno-Manzano V
    Cell Transplant; 2015; 24(8):1493-509. PubMed ID: 25198194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurogenic bladder model for spinal cord injury: spinal cord microdialysis and chronic urodynamics.
    Smith CP; Somogyi GT; Bird ET; Chancellor MB; Boone TB
    Brain Res Brain Res Protoc; 2002 Feb; 9(1):57-64. PubMed ID: 11852271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder.
    Tsang B; Stothers L; Macnab A; Lazare D; Nigro M
    Neurourol Urodyn; 2016 Mar; 35(3):354-64. PubMed ID: 25620137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review.
    Best KL; Ethans K; Craven BC; Noreau L; Hitzig SL
    J Spinal Cord Med; 2017 Sep; 40(5):505-529. PubMed ID: 27734771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
    Munoz A; Somogyi GT; Boone TB; Smith CP
    Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat.
    Urakami S; Shiina H; Enokida H; Kawamoto K; Kikuno N; Fandel T; Vejdani K; Nunes L; Igawa M; Tanagho EA; Dahiya R
    World J Urol; 2007 Apr; 25(2):207-13. PubMed ID: 17221271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.